Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +67.3% | +191.2% | 3 / 3 | +12.9% | +0.62 pp | +1.20 pp | +7.5% | 0.26 | 4.47 | 128 | +12,9% | 4,7 | +67,3% | 4.47 | 12.31 | −63,7% |
| Pts | 12 | 12 | 12 | 4 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 13.000 (close price on 2026-10-19)EPS (TTM): 2.907
Financial charts
1.Revenue & growth
VND bn128Q2/26
1.Revenue & growth
VND bn128Q2/26
2.Profit & growth
VND bn4,74Q2/26
3.Profit mix (Penman)
VND bn19,3Q2/26
4.Margins & cost structure
%15.7%Q2/26
5.Returns & cash cycle
% · days6.7%Q2/26
6.Earnings quality & cash
VND bn38,8Q2/26
7.Asset structure
VND bn375Q2/26
8.Funding & debt health
VND bn · times375Q2/26
9.Revenue backlog
VND bn1,82Q2/26
10.Valuation
times · %4,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %768Q2/26
Adjusted EPS growth, latest quarter
67.3%
Average adjusted EPS growth, 3 quarters
48.8%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26